-
With visas denied, Senegal World Cup fans watch from afar
-
Crystal Palace appoint Sage as manager
-
Trump says Strait of Hormuz will be 'completely open' Friday
-
Brazil's Splitter to become new NBA Bulls coach: reports
-
Greed or player health? 'Damaging' World Cup drinks breaks under spotlight
-
Murdochs' Fox to acquire US streaming giant Roku
-
Argentine mining threatens scarce water resources in the Andes
-
Abdullah Ibrahim, world-renowned South African jazz pianist
-
Deschamps points to Spain as team to beat at World Cup
-
Tunisian football bosses mull firing Lamouchi after World Cup thrashing
-
Timeline of Trump-linked resort project in Albania
-
Relegated Wolves appoint Peixoto as new manager
-
New Zealand need collective effort to replace Williamson: Ravindra
-
IMF chief warns energy recovery to take time after US-Iran ceasefire
-
Lebanese mourn destroyed homes, livelihoods in southern city
-
Amazonian tribal leader Raoni hospitalized in intensive care
-
Trump faces G7 as questions swirl on Iran accord
-
England to give debuts to Cox and Baker against New Zealand
-
France shuts down dozen Israeli stands at defence trade show
-
Launch 3 Telecom Secures New Lakeland Facility
-
England coach McCullum 'worried' about Stokes after curfew incident
-
Sevilla's Mir sentenced to 8.5 years in prison for sexual assault
-
'They want to destroy us': Shock and anger as Russian attack sets Kyiv cathedral ablaze
-
'Start your engines'? Shipping groups wary on Hormuz reopening
-
Oil plunges, stocks jump on US-Iran peace deal
-
WHO, Lula urge G7 action on finishing pandemic treaty
-
US-Iran deal met with hope, scepticism in Mideast
-
Trump threatens 100% tariff on French wines over digital tax
-
German working-age population to shrink dramatically: study
-
MSF warns of 'dangerous gaps' in Ebola response in DR Congo
-
Three things we learned from the Barcelona Grand Prix
-
Real Madrid confirm Cucurella signing from Chelsea
-
At least 2,300 killed this year in Haiti gang violence: UN
-
G7 allies seek common ground with Trump after Iran accord
-
Hope for peace with North, but not unification at S. Korea festival
-
Iran take center stage at World Cup as Spain make bow
-
Kyrgyzstan bets on reality TV to tackle obesity crisis
-
Burnt-out Indonesians beat the blues with children's games
-
Greek fishermen struggle to keep up with pufferfish invaders
-
Blood sport at the White House for Trump's 80th birthday
-
Broeders-Bol backed by coach to challenge the very best over 800m
-
Sweden demolish Tunisia 5-1 to seize control of World Cup group
-
'For sure': Macron to preach stronger Europe vision at G7 swansong
-
France hosts G7 dominated by Trump, Iran
-
Carolina beat Vegas to end 20-year wait for second Stanley Cup
-
Middle East war: peace deal reactions
-
Crude prices plunge, stocks surge on US-Iran peace deal
-
Deadly strikes on Ukraine leave Kyiv cathedral in flames
-
Driven O'Brien looks to bring up ton at Ascot to ring in 30 years of glory
-
First major bump but prodigy Seixas still headed for the top
Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
M.Odermatt--BTB